Connie Chein
Obstetrics & Gynecology · Beverly Hills, CANPI 1851327431
Payments from drug & device makers
Across 118 payments — averaging $17.48 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$511
- Therapeuticsmd, Inc.$473
- Mayne Pharma Commercial LLC$244
- Exeltis, USA Inc.$225
- Shield Therapeutics Inc$153
- Exact Sciences$73
- plus $383 from 12 others
What the payments were for
- Food & beverage$2,062100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 34 | $511 |
| Therapeuticsmd, Inc. | 29 | $473 |
| Mayne Pharma Commercial LLC | 18 | $244 |
| Exeltis, USA Inc. | 10 | $225 |
| Shield Therapeutics Inc | 6 | $153 |
| Exact Sciences | 3 | $73 |
| Ascend Therapeutics US, LLC | 3 | $59 |
| Avion Pharmaceuticals | 3 | $58 |
| Roche Diagnostics Corporation | 2 | $47 |
| Evofem Biosciences, Inc. | 2 | $40 |
| Amgen | 1 | $30 |
| Biohaven Pharmaceutical Holding Company Ltd. | 1 | $26 |
| Vertical Pharmaceuticals, LLC | 1 | $24 |
| IBSA Pharma Inc. | 1 | $24 |
| Pfizer | 1 | $20 |
| Aspira Women's Health Inc | 1 | $20 |
| Lupin Inc. | 1 | $17 |
| Myovant Sciences Inc. | 1 | $17 |
How this compares
$2,062 in reported general payments places this provider in the 75th percentile of 3,784 obstetrics & gynecology providers in California.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| ImvexxyEstradiol | 72 | $19,077 |
| FyavolvNorethindrone Ac/Eth Estradiol | 61 | $6,065 |
| Estradiol (Twice Weekly)Estradiol | 54 | $5,257 |
| ValacyclovirValacyclovir Hcl | 52 | $4,618 |
| Estradiol | 82 | $4,043 |
| PremarinEstrogens, Conjugated | 15 | $3,103 |
| Estradiol-Norethindrone AcetatEstradiol/Norethindrone Acet | 28 | $2,188 |
| Norethindron-Ethinyl EstradiolNorethindrone Ac/Eth Estradiol | 25 | $1,642 |
| Metronidazole | 32 | $1,437 |
| JinteliNorethindrone Ac/Eth Estradiol | 12 | $1,184 |
| Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst | 84 | $1,134 |
| Terconazole | 43 | $1,029 |
| Acyclovir | 22 | $870 |
| Methenamine Hippurate | 14 | $508 |
| Nystatin-TriamcinoloneNystatin/Triamcinolone Acet | 16 | $376 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Therapeuticsmd, Inc.Imvexxy | $473 | $19,07772 claims |
| PfizerPremarin | $20 | $3,10315 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 3,784 obstetrics & gynecology providers in California.
Other obstetrics & gynecology in Beverly Hills
- Peyman BanooniBeverly Hills$9.2M
- Michael BroderBeverly Hills$100K
- Vellore BhupathyWhittier$4.3M
- Edwin RamirezOxnard$3.5M
- Nam TranSan Francisco$3M
- Dmitriy RomanenkoSouth Gate$2.7M
- Anita NelsonTorrance$2.1M
- Oleg BessLos Angeles$1.7M
- Rovena ReaganSan Diego$1.7M
- Dana Shippdel Mar$1.7M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.